Recent Media Coverage

View All
2021-09-28 research healey-center-for-als;neurology
ALS News TodaySeptember | 28 | 2021

Early Access to CNM-Au8 Given to Patients Ineligible for HEALEY Trial

ALS News Today covers efforts to enroll additional people with ALS in expanded access programs for an experimental ALS treatment, even when they do not qualify for participation in a clinical trial.

2021-09-13 research healey-center-for-als;neurology
BioSpaceSeptember | 13 | 2021

Amylyx Pharmaceuticals Donates CENTAUR Clinical Trial Data and Participant Samples

Amylyx Pharmaceuticals has donated data and biological samples generated by the CENTAUR clinical trial that evaluated the safety and efficacy of AMX0035 in participants with amyotrophic lateral sclerosis (ALS). The donations will be managed by groups at the Healey Center for ALS and the Barrow Neurological Institute.